ORIGINAL ARTICLES
Knowledge and expectations of patients receiving aeroallergen immunotherapy

https://doi.org/10.1016/S1081-1206(10)61511-6Get rights and content

Background

Patients receiving aeroallergen immunotherapy frequently have poor knowledge and unfounded expectations of various important aspects of their treatment.

Objectives

To evaluate patients' knowledge about the content, benefit, and risk related to the aeroallergen immunotherapy that they were receiving.

Methods

A self-administered questionnaire was distributed to all patients older than 16 years who had undergone aeroallergen immunotherapy for allergic rhinitis at 3 university-affiliated allergy clinics.

Results

A total of 132 patients (77 males and 57 females; mean ± SD age, 30 ± 13 years) participated in the study. The mean ± SD duration of treatment was 30 ± 60 months. Complete recovery of their allergies was expected by 39% of the patients. One fifth of the study group did not know when improvement should be expected, and 18% anticipated improvement to occur within days or weeks from the initiation of treatment. Only 32% were aware that immunotherapy might have some potential risk or adverse effects, and 24.2% failed to identify at least one of the allergens they were receiving. Patients who were interviewed during their first 6 months of aeroallergen immunotherapy had more knowledge about it than those who had been undergoing long-term treatment.

Conclusions

There is a grave lack of knowledge and numerous misconceptions among substantial numbers of patients receiving aeroallergen immunotherapy. More educational effort is needed to increase patients' knowledge about immunotherapy before and during aeroallergen immunotherapy to improve their compliance and the success and safety of this therapeutic modality.

REFERENCES (18)

There are more references available in the full text version of this article.

Cited by (34)

  • Patient expectations in asthma care

    2021, Revue des Maladies Respiratoires
  • Sublingual immunotherapy: World Allergy Organization position paper 2013 update

    2014, World Allergy Organization Journal
    Citation Excerpt :

    About a decade ago, a survey-based study documented that 39% of patients expected complete recovery from their allergies, 20% of patients had no idea about the timing of anticipated improvement, and 18% expected improvement to occur within days. Furthermore, 60% of patients were unaware of any specified appropriate treatment duration, 33% considered immunotherapy to be without side effects, and only 3.3% of patients correctly identified all of the allergens to which they were undergoing desensitization [338]. A more recent, cross-sectional, Italian multicenter survey in a large cohort treated with subcutaneous immunotherapy (SCIT) or SLIT found that, despite some gaps and misconceptions, the majority of patients had an adequate level of knowledge, perception, expectations, and satisfaction about AIT that was similar to the level of results expected by physicians [339].

  • Allergy immunotherapy adherence and delivery route: Location does not matter

    2014, Journal of Allergy and Clinical Immunology: In Practice
  • Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: A survey

    2013, Respiratory Medicine
    Citation Excerpt :

    In addition, correspondence with the physician’s view was assessed. Our data confirm and extend previously published experience with SIT.8,10,14 Allergen-specific immunotherapy is a valuable causal treatment for respiratory allergies.

View all citing articles on Scopus
View full text